Advertisement

Topics

Minomic Completes Prospective Clinical Study Using MiCheck® to Assist in Diagnosis of Prostate Cancer

00:14 EDT 17 May 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
58% Fewer patients proceed to Biopsy US Rollout well advanced Australian immuno-oncology company Minomic International Ltd is pleased to announce the completion of its prospective clinical tria...

Other Sources for this Article

Minomic International Ltd
Brad Walsh, Ph.D., +61 413-231-296
Chief Executive Officer

NEXT ARTICLE

More From BioPortfolio on "Minomic Completes Prospective Clinical Study Using MiCheck® to Assist in Diagnosis of Prostate Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...